Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxRestructuring CostsRevenueSelling, General & AdministrativeTax ProvisionsTax Rate
Others
Ratios

Accendra Health (ACH) Cost of Revenue (2016 - 2025)

Historic Cost of Revenue for Accendra Health (ACH) over the last 17 years, with Q3 2025 value amounting to $375.1 million.

  • Accendra Health's Cost of Revenue rose 563.04% to $375.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $10.3 billion, marking a year-over-year increase of 11145.0%. This contributed to the annual value of $8.5 billion for FY2024, which is 332.47% up from last year.
  • Accendra Health's Cost of Revenue amounted to $375.1 million in Q3 2025, which was up 563.04% from $357.3 million recorded in Q2 2025.
  • In the past 5 years, Accendra Health's Cost of Revenue ranged from a high of $7.4 billion in Q4 2024 and a low of $344.4 million during Q2 2024
  • For the 5-year period, Accendra Health's Cost of Revenue averaged around $2.0 billion, with its median value being $2.0 billion (2023).
  • Data for Accendra Health's Cost of Revenue shows a peak YoY increase of 25681.77% (in 2024) and a maximum YoY decrease of 8315.04% (in 2024) over the last 5 years.
  • Over the past 5 years, Accendra Health's Cost of Revenue (Quarter) stood at $2.1 billion in 2021, then rose by 0.87% to $2.1 billion in 2022, then decreased by 2.69% to $2.1 billion in 2023, then surged by 256.82% to $7.4 billion in 2024, then crashed by 94.96% to $375.1 million in 2025.
  • Its Cost of Revenue stands at $375.1 million for Q3 2025, versus $357.3 million for Q2 2025 and $2.1 billion for Q1 2025.